| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/03/2003 | US20030064475 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/03/2003 | US20030064471 Integrin cell surface receptor for use as tool in the treatment of cancer |
| 04/03/2003 | US20030064470 Ligand for use as tool in the treatment of tumors in humans |
| 04/03/2003 | US20030064469 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 04/03/2003 | US20030064468 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 04/03/2003 | US20030064467 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 04/03/2003 | US20030064466 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders |
| 04/03/2003 | US20030064465 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064464 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064463 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064462 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064461 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064460 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064459 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064458 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064457 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064456 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064455 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders |
| 04/03/2003 | US20030064451 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064450 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064449 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064448 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064447 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064446 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064445 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064444 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064443 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064442 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064430 Novel steroid-activated nuclear receptors and uses therefor |
| 04/03/2003 | US20030064420 Antibody to hepatocyte growth factor activator inhibitor-1 and use thereof |
| 04/03/2003 | US20030064416 Diagnostic kit for use in diagnosis of alzheimer's disease |
| 04/03/2003 | US20030064407 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064406 Process for analyzing annexin-V in urine, and application thereof |
| 04/03/2003 | US20030064391 Preparation of sequences on substrate; obtain substrate, deposit on plate surface, incubate with activator, remove protective groups, recover biopolymer |
| 04/03/2003 | US20030064389 Isolating preferential antibodies; obtain sample containing antibody, incubate with antigen, incubate with modulator of antibody binding, recover antibody |
| 04/03/2003 | US20030064383 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer |
| 04/03/2003 | US20030064375 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of kidney, nervous system and arthritic disorders |
| 04/03/2003 | US20030064369 Novel proteins and nucleic acids encoding same |
| 04/03/2003 | US20030064367 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030064361 Preparing viral vaccine; obtain glycoprotein, determine neutralizing epitope, generate vaccine associated with neutralizing epitope |
| 04/03/2003 | US20030064359 Preparation of highly-purified plasma membranes |
| 04/03/2003 | US20030064075 For diagnosis, therapy and prophylaxis of malaria; vaccines |
| 04/03/2003 | US20030064071 Method of using a facilitator of retroviral entry into cells |
| 04/03/2003 | US20030064070 Administering multiple treatment cycles of an anti-TNF (tumor necrosis factor) alpha antibody to individual, each treatment cycle, other than the first, is administered once loss of response to the previous treatment cycle has occurred |
| 04/03/2003 | US20030064069 Specific binding members for TGFbeta1 |
| 04/03/2003 | US20030064068 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 04/03/2003 | US20030064067 Inducing differentiation and/or promoting proliferation of regulatory T cells, comprising allowing a CD3 agonist and a 4C8 antigen agonist to act on an immunocyte expressing CD3 and 4C8 antigens |
| 04/03/2003 | US20030064066 For inhibiting cell division and/or resulting in apoptosis |
| 04/03/2003 | US20030064065 35 kappaD tumor associated protein antigen: uses and methods detection |
| 04/03/2003 | US20030064064 Administering formulation that inhibits activity of IgE(immunoglobulin E) sufficient to decrease the activity of IgE and administering to the subject second formulation amount of the antigen sufficient to modulate the immune response |
| 04/03/2003 | US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy |
| 04/03/2003 | US20030064062 For use in pharmaceuticals, diagnostics, biosensors and bioreactors |
| 04/03/2003 | US20030064000 Methods of sterilizing biological mixtures using stabilizer mixtures |
| 04/03/2003 | US20030063112 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/03/2003 | US20030062053 Surgical method for the delivery of saliva-borne antibodies to the blood stream for the treatment of infectious diseases |
| 04/03/2003 | CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2820144A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2469230A1 Antibody inhibitors of gdf-8 and uses thereof |
| 04/03/2003 | CA2461714A1 Treatment of chronic joint inflammation |
| 04/03/2003 | CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | CA2461529A1 Recombinant anti-osteopontin antibody and use thereof |
| 04/03/2003 | CA2461471A1 Antibody and use thereof |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461351A1 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460803A1 Antibody against metastin and use thereof in diagnosing pregnancy |
| 04/03/2003 | CA2460644A1 Methods of sterilizing biological materials containing non-aqueous solvents |
| 04/03/2003 | CA2459827A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2459807A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/02/2003 | EP1298436A2 Beta-amyloid peptide (BAP) release inhibitor compounds for treating BAP-related diseases and methods for their identification |
| 04/02/2003 | EP1298219A1 Method of assaying the function of fc fragment of antibody |
| 04/02/2003 | EP1298211A2 Polynucleotide segment of HPV16 Genome |
| 04/02/2003 | EP1298207A1 Methods of producing protein libraries and selection of proteins from them |
| 04/02/2003 | EP1298205A1 Novel lipase |
| 04/02/2003 | EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1 |
| 04/02/2003 | EP1297848A1 Preventives/remedies for granuloma |
| 04/02/2003 | EP1297847A2 Anti-CD18 antibodies in stroke |
| 04/02/2003 | EP1297846A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 04/02/2003 | EP1297168A2 Expression vectors |
| 04/02/2003 | EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 04/02/2003 | EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 04/02/2003 | EP1297142A2 Dual specificity antibodies and methods of making and using |
| 04/02/2003 | EP1297141A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
| 04/02/2003 | EP1297139A2 G-protein coupled receptor org10 |
| 04/02/2003 | EP1297138A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 04/02/2003 | EP1297137A2 Gp286 nucleic acids and polypeptides |
| 04/02/2003 | EP1297136A2 Full length human hcn1 ih channel subunit and variants |
| 04/02/2003 | EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 04/02/2003 | EP1297133A2 Gp354 nucleic acids and polypeptides |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297128A2 G-protein coupled receptors |
| 04/02/2003 | EP1297127A2 Gpr22 modulators as appetite-control agents |
| 04/02/2003 | EP1297126A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus |
| 04/02/2003 | EP1297124A2 Generation of libraries of antibodies in yeast and uses thereof |
| 04/02/2003 | EP1297114A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |
| 04/02/2003 | EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 04/02/2003 | EP1297016A2 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297013A2 Use of taci as an anti-tumor agent |